Robert J. Mulroy
Fondateur chez Partner Therapeutics, Inc.
Profil
Robert J.
Mulroy founded Partner Therapeutics, Inc., where he worked as Chief Executive Officer & Director.
Mr. Mulroy also formerly worked at Merrimack Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2011 to 2016.
Mr. Mulroy received his undergraduate degree from Stanford University and graduate degree from Yale University.
Postes actifs de Robert J. Mulroy
| Sociétés | Poste | Début |
|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Fondateur | - |
Anciens postes connus de Robert J. Mulroy
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur Général | 03/10/2016 |
Formation de Robert J. Mulroy
| Stanford University | Undergraduate Degree |
| Yale University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
